Taxonomy Code 1835X0200X(1835x0200x)
Oncology Pharmacist. Providers: 14
Select City
E
G
M
S
W
Oncology Pharmacist Providers
| NPI | Name | Type | Address |
|---|---|---|---|
|
Joseph Anthony Theisen |
Individual |
600 Highland Ave Compliance Mail Code 2433 Madison, WI |
|
|
PHARM.D. Felicia Falvo |
Individual |
9200 W Wisconsin Ave Milwaukee, WI |
|
|
DR. PHARMD Kristina L Teso |
Individual |
9200 W Wisconsin Ave Milwaukee, WI |
|
|
PHARMD, BCOP Angela M Urmanski |
Individual |
9200 W Wisconsin Ave Milwaukee, WI |
|
|
DR. PHARMD Monica Koca |
Individual |
9200 W Wisconsin Ave Froedtert Hosp-inpatient Pharmacy Milwaukee, WI |
|
|
MRS. PHARMD Emilie Joanne Aschenbrenner |
Individual |
N65w27505 Maple St Sussex, WI |
|
|
MS. R.PH. Kathleen Patricia Kovatovic |
Individual |
9200 W Wisconsin Ave Milwaukee, WI |
|
|
PHARM D Steven Daniel Meyers |
Individual |
N17w24100 Riverwood Dr Ste 100 Waukesha, WI |
|
|
PHARMD Eve-michelle Segal |
Individual |
9200 W Wisconsin Ave Milwaukee, WI |
|
|
DR. PHARMD Cole R Lightfoot |
Individual |
9200 W Wisconsin Ave Milwaukee, WI |
|
|
DR. PHARMD Kaitlyn Jennifer Bailey |
Individual |
1400 Bellinger St Eau Claire, WI |
|
|
PHARMD Lindsey Jung |
Individual |
600 Highland Avenue Madison, WI |
|
|
Jessica Mckernan |
Individual |
600 Highland Ave Pharmacy Administration Office Room F6/175, Mc 1530 Madison, WI |
|
|
PHARMD Nicole Lynn Zimmerman |
Individual |
2851 University Ave Green Bay, WI |
How to obtain, renew, or terminate an NPI
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
| Taxonomy Code | 1835X0200X |
| Specialization | Oncology |
| Display Name | Oncology Pharmacist |
| Taxonomy Group | Pharmacy Service Providers |
| Taxonomy Classification | Pharmacist |
| Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
| Effective Date | September 30, 2009 |